Home|Journals|Articles by Year|Audio Abstracts

Original Research

AAM. 2023; 12(2): 146-157

Effect of ASA-20 (Ayush Kwath, Samsamani Vati, Anu Taila) as a prophylactic measure for COVID-19 in High-Risk population – A prospective interventional study

Pradip Kumar Goswami,Sikha Lekharu,Rehana Parveen,Abhishek Bhattacharjee,Himangshu Baruah,Bishnu Choudhury.


Background: The SARS Cov-2, has emerged as one of the biggest global health threats of the 21st century. It symptomatically varies from having mild to severe symptoms with fever, cough, breathing difficulty, anosmia, diarrhea etc. With the frequent changing protocols and no drug of choice till date, the management of COVID-19 can be structured through some preventive measures/medicines.
Aims and Objectives: To assess the efficacy of ASA-20 (Ayush kwath, Samsamani vati, Anu taila) in preventing COVID-19 infection in healthy volunteers as a prophylactic measure among high-risk populations (Health Care Workers/Containment Zone & Quarantined Population) exposed to COVID-19.
Materials and Methods: A total of 5000 subjects aged between 18 to 68 years were enrolled in to the study and non randomly divided into two groups. Subjects in Group-A (trial group) were given ASA-20 orally for 30 days along with standard preventive care as recommended by ICMR while subjects enrolled in Group-B (control group) were advised to follow only standard preventive care. Assessment was made based on Immune status questionnaire, general health questionnaire and COVID-19 positivity status during the study period. Follow ups were done on day 1, 15, 30 and 45. Statistical analysis was done by using Chi-square test and Fisher test.
Results: 0.80% and 1.79% subjects were found to have tested positive in the trial and control group respectively. The results show that control group is 2.26 times more likely to contract COVID-19 than the trial group. In other words, the medicine is effective in reducing the contraction of COVID-19 by more than half.

Key words: Ayush Kwath, Anu Taila, COVID-19, prophylaxis, Samsamani Vati

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.